Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy

Key Points

• Cognitive dysfunction correlates with elevated disease burden indicators in patients with progressive supranuclear palsy.
• This analysis highlights significant associations between specific fluid biomarkers and cognitive symptoms, with specific metrics identified.
• Observational analysis using data from a clinical registry contributes insights into the disease mechanisms at play.
• Findings suggest that understanding these fluid biomarkers may lead to better diagnostic and treatment strategies.